|
CASP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.96759974769157E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.02839975319102E-10 |
| Normal-vs-Stage2 |
9.960400E-01 |
| Normal-vs-Stage3 |
3.34379999999967E-06 |
| Normal-vs-Stage4 |
2.862300E-03 |
| Stage1-vs-Stage2 |
6.572100E-04 |
| Stage1-vs-Stage3 |
9.863200E-01 |
| Stage1-vs-Stage4 |
3.804600E-01 |
| Stage2-vs-Stage3 |
2.764200E-03 |
| Stage2-vs-Stage4 |
2.960400E-02 |
| Stage3-vs-Stage4 |
4.272000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.55919951896999E-10 |
| Normal-vs-AfricanAmerican |
5.436000E-02 |
| Normal-vs-Asian |
1.89850000054115E-07 |
| Caucasian-vs-AfricanAmerican |
5.053800E-01 |
| Caucasian-vs-Asian |
2.485200E-01 |
| AfricanAmerican-vs-Asian |
1.610190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.78189999924905E-08 |
| Normal-vs-Female |
1.54259999995965E-07 |
| Male-vs-Female |
2.911700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.2890000178345E-09 |
| Normal-vs-Age(41-60Yrs) |
7.9305000000085E-05 |
| Normal-vs-Age(61-80Yrs) |
4.483200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.070000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.339800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.765700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.389600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.839400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.482440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.203200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.585570E-01 |
| Classical-VS-Follicular |
2.49209997083E-09 |
| Classical-VS-Other |
3.471400E-01 |
| Classical-VS-Normal |
5.96966920340947E-13 |
| Tall-VS-Follicular |
1.0073999999749E-06 |
| Tall-VS-Other |
8.417400E-01 |
| Tall-VS-Normal |
2.91019999998365E-06 |
| Follicular-VS-Other |
5.023200E-03 |
| Follicular-VS-Normal |
5.127600E-01 |
| Other-VS-Normal |
7.865600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.817200E-04 |
| Normal-vs-N1 |
5.9550999999991E-05 |
| N0-vs-N1 |
5.016400E-02 |
|
|
